C0243095||NAPS
C0026769||multiple sclerosis
C1172734||Natalizumab
C0037313||Sleep
C0026769||Multiple Sclerosis
C0026769||multiple sclerosis
C0026769||multiple sclerosis
C0015672||fatigue
C2939186||mood disturbance
C0338656||cognitive impairments
C1257890||populations
C0012634||Disease
C0450442||agents
C0001721||affect
C0037313||sleep
C1172734||natalizumab
C0015672||fatigue
C0087111||therapy
C0243095||NAPS
C0026769||multiple sclerosis
C2603343||study
C1172734||natalizumab
C0037313||sleep
C0162701||polysomnography
C0162701||polysomnography
C0519186||multiple sleep latency testing
C0519186||multiple sleep latency testing
C0026769||multiple sclerosis
C0015672||fatigue
C2830004||sleepiness
C0087111||therapy
C0015672||fatigue
C0026516||mood
C0009240||cognition
C0037313||sleep
C0162701||polysomnography
C0519186||multiple sleep latency testing
C1172734||natalizumab
C0574032||infusion
C3810705||Modified Fatigue Impact Scale
C3813323||Fatigue Severity Scale
C3813323||Fatigue Severity Scale
C3541276||Epworth Sleepiness Scale
C3541276||Epworth Sleepiness Scale
C3826867||visual analogue scale for fatigue
C3826867||visual analogue scale for fatigue
C1172734||natalizumab
C0574032||infusions
C0451221||Hospital Anxiety and Depression Scale
C0451221||Hospital Anxiety and Depression Scale
C1172734||natalizumab
C0574032||infusions
C0037313||sleep
C0043012||wakefulness
C0519186||multiple sleep latency
C0087111||therapy
C3813323||Fatigue Severity Scale
C3826867||visual analogue scale for fatigue
C3541276||Epworth Sleepiness Scale
C0451221||Hospital Anxiety and Depression Scale
C0087111||therapy
C0087111||treatment
C1172734||natalizumab
C0015672||fatigue
C2830004||sleepiness
C0026516||mood
C0037313||sleep